Brief Report About the Role of HIPEC in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer... Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, January 24, 2017

Brief Report About the Role of HIPEC in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer...



NCBI

 Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al.
Int J Gynecol Cancer. 2017 Feb;27(2):246-247. doi: 10.1097/IGC.0000000000000864.

Author information

  • 1*Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte, Essen; †Coordinating Center for Clinical Trials, Philipps-University Marburg, Marburg; ‡Department of Gynecology, Charité, Berlin, Germany; and §Department of Gynecology Oncology, MD Anderson Cancer Center, Madrid, Spain.

Abstract

A published so-called phase 3 study regarding HIPEC in ovarian cancer raised multiple questions. This commentary focusses on the weakness of the publication and discusses this in detail.
PMID:
28114231
DOI:
10.1097/IGC.0000000000000864
[PubMed - in process] (note: above link not working??)

0 comments :

Post a Comment

Your comments?